Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroendocrine activation in left ventricular dysfunction

R Ferrari, C Ceconi

    European Heart Journal
    |November 20, 1998
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gender differences in the effects of cardiovascular drugs.

    European heart journal. Cardiovascular pharmacotherapy·2017
    Same author

    Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.

    British journal of pharmacology·2011
    Same author

    Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.

    Cardiovascular drugs and therapy·2011
    Same author

    Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL.

    International journal of cardiology·2010
    Same author

    Effects of treatment strategy on endothelial function.

    Autoimmunity reviews·2010
    Same author

    Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies.

    Cardiovascular drugs and therapy·2007
    Same journal

    The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

    European heart journal·2026
    Same journal

    Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

    European heart journal·2026
    Same journal

    Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

    European heart journal·2026
    Same journal

    Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

    European heart journal·2026
    Same journal

    Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

    European heart journal·2026
    Same journal

    Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

    European heart journal·2026
    See all related articles